STAT July 18, 2024
Rachel Cohrs Zhang, John Wilkerson

WASHINGTON — BIO’s new CEO John Crowley is making changes.

He’s pivoting the biotechnology industry’s largest trade association away from a focus on controversial social issues. He dramatically restructured the organization and laid off around 30 employees to focus on new areas including vaccine education and women’s health.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
New 'how-to guide' for future rapid vaccine development
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
Sanofi adds new $600M manufacturing plant
Biden administration pushes anti-obesity drug pressure to Trump

Share This Article